Institutul Regional De Oncologie Iasi
- Address
- lock Available on a paid plan
Oncology
At Institutul Regional De Oncologie Iasi, clinical research is centered on oncology, with studies focused on major cancer types and the search for better ways to manage and understand malignant disease. The trials are designed to support improved treatment options and more effective care for patients.
- Research on cancer care and treatment improvement
- Studies exploring new approaches for oncology patients
With a team of 17 investigators, the site contributes to advancing cancer research in Iasi and supports the development of more effective therapies and patient care strategies.
Clinical Research
The clinical trial activity at this Romanian research center includes efforts aimed at improving diagnosis, treatment evaluation, and overall understanding of serious disease. These studies help generate evidence that can guide better clinical decisions and patient management.
- Evaluation of treatment effectiveness in medical research
- Studies supporting better diagnosis and disease monitoring
This work reflects the site’s role as an active clinical research location in Europe, contributing to evidence-based care through carefully designed studies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 10 therapeutic areas and 15 of 171 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 171 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 23 by active trials.
lock +22 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institutul Regional De Oncologie Iasi
lock Showing 1 of 77 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects with TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy | Kartos Therapeutics Inc. | Phase IV | Not Recruiting | Aug 2023 | Jul 2024 |
IMP list
lock Showing 1 of 171 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 17 | Unknown | 2023-11-13 | 2026-05-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.